Eli Lilly: Goldman Sachs raised the target price from $740 to $785

Zhitong FinanceMay 31 03:43

Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TipRanksMay 30 22:04

Balanced Outlook Amidst Strategic Shifts: Pfizer's Hold Rating Explained

TipRanksMay 30 21:59

Pfizer's Acoramidis Shows Promising Survival Trends: A Buy Rating Endorsement

TipRanksMay 30 21:16

Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740

MT NewswiresMay 30 07:32

Barclays Sticks to Their Buy Rating for Elanco Animal Health (ELAN)

TipRanksMay 29 04:48

Analysts Are Bullish on Top Healthcare Stocks: Merus (MRUS), Royalty Pharma (RPRX)

TipRanksMay 28 19:13

Royalty Pharma's Strategic Acquisitions and Compelling Valuation Warrant a Buy Rating

TipRanksMay 28 18:56

Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanksMay 28 00:15

Jefferies Adjusts Price Target on Eli Lilly to $925 From $915

MT NewswiresMay 23 06:03

Royal Bank of Canada: Reiterates the Johnson & Johnson (JNJ.US) rating and adjusted from superior to superior market rating, with a target price of $175.00.

Zhitong FinanceMay 22 09:10

Johnson & Johnson Analyst Ratings

BenzingaMay 22 09:07

Wells Fargo Remains a Hold on Pfizer (PFE)

TipRanksMay 22 04:45

Bristol-Myers Squibb (BMY) Gets a Hold From Wells Fargo

TipRanksMay 22 04:45

DA Davidson Raises Price Target on Pfizer to $35 From $30, Maintains Buy/Add Rating

MT NewswiresMay 20 06:16

Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ)

TipRanksMay 20 06:17

Analysts' Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Elanco Animal Health (ELAN)

TipRanksMay 17 06:21

Royal Bank of Canada: Reiterates the Johnson & Johnson (JNJ.US) rating and adjusted from superior to superior market rating, with a target price of $175.00.

Zhitong FinanceMay 16 11:50

Johnson & Johnson Analyst Ratings

BenzingaMay 16 11:43

RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target

BenzingaMay 16 11:45